Drugs / LIXUMISTAT
LIXUMISTAT
also known as
IM156 · HL-156A · HL-156A FREE BASE · HL271 · HL271 ACETATE · IM-156 FREE BASE · LIXUMISTAT ACETATE
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05497778 | Oct 2022 → Feb 2027 expected | pancreatic ductal adenocarcinoma | M.D. Anderson Cancer Center | Active not recruiting | No outcome recorded |
| Phase 1 | NCT03272256 | Oct 2017 → Dec 2019 | neoplasm | ImmunoMet Therapeutics, Inc. | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2025-01-01 | ImmunoMet Therapeutics, Inc. | Results ASCO GI 2025 immunomet.com ↗
ImmunoMet Therapeutics presented Phase 1b/2a interim data for lixumistat (IM156) in advanced pancreatic cancer at the ASCO Gastrointestinal Cancers Symposium in San Francisco, January 2025. |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2025-01-01 | ImmunoMet Therapeutics, Inc. | ASCO GI 2025 immunomet.com ↗ |
| 2018-05-24 | HanAll BioPharma Co., Ltd. | IM156, a new drug with original technology of HanAll Biopharma, is to be Introduced at the American Society of Clinical Oncology hanall.com ↗ |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LIXUMISTAT | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650733 ↗ |
| Known as | HL-156A | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650733 ↗ |
| Known as | HL-156A FREE BASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650733 ↗ |
| Known as | HL271 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650733 ↗ |
| Known as | HL271 ACETATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650733 ↗ |
| Known as | IM-156 FREE BASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650733 ↗ |
| Known as | IM156 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05497778 ↗ |
| Known as | LIXUMISTAT ACETATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650733 ↗ |
| Modality | Small molecule | — CHEMBL4650733 ↗ |
| Route | Oral | “Given by PO” NCT05497778 ↗ |